Cargando…
Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial
BACKGROUND: Premature birth is considered one of the main problems in modern Obstetrics. It causes more than 50 % of neonatal mortality; it is responsible for a large proportion of infant morbidity and incurs very high economic costs. Cervical length, which can be accurately measured by ultrasound,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584019/ https://www.ncbi.nlm.nih.gov/pubmed/26407852 http://dx.doi.org/10.1186/s13063-015-0964-y |
_version_ | 1782391923553599488 |
---|---|
author | Cabrera-García, Lourdes Cruz-Melguizo, Sara Ruiz-Antorán, Belén Torres, Ferrán Velasco, Ana Martínez-Payo, Cristina Avendaño-Solá, Cristina |
author_facet | Cabrera-García, Lourdes Cruz-Melguizo, Sara Ruiz-Antorán, Belén Torres, Ferrán Velasco, Ana Martínez-Payo, Cristina Avendaño-Solá, Cristina |
author_sort | Cabrera-García, Lourdes |
collection | PubMed |
description | BACKGROUND: Premature birth is considered one of the main problems in modern Obstetrics. It causes more than 50 % of neonatal mortality; it is responsible for a large proportion of infant morbidity and incurs very high economic costs. Cervical length, which can be accurately measured by ultrasound, has an inverse relationship with the risk of preterm birth. As a result, having an effective intervention for asymptomatic patients with short cervix could reduce the prematurity. Although recently published data demonstrates the effectiveness of vaginal progesterone and cervical pessary, these treatments have never been compared to one another. METHODS/DESIGN: The PESAPRO study is a noncommercial, multicenter, open-label, randomized clinical trial (RCT) in pregnant women with a short cervix as identified by transvaginal ultrasonography at 19 to 22 weeks of gestation. Patients are randomized (1:1) to either daily vaginal progesterone or cervical pessary until the 37th week of gestation or delivery; whichever comes first. During the trial, women visit every 4 weeks for routine questions and tests. The primary outcome is the proportion of spontaneous preterm deliveries before 34 weeks of gestation. A sample size of 254 pregnant women will be included at 29 participating hospitals in order to demonstrate noninferiority of placing a pessary versus vaginal progesterone. The first patient was randomized in August 2012, and recruitment of study subjects will continue until the end of December 2015. DISCUSSION: This trial assesses the comparative efficacy and safety between two accepted treatments, cervical pessary versus vaginal progesterone, and it will provide evidence in order to establish clinical recommendations. TRIAL REGISTRATION: EU Clinical Trials Register EudraCT2012-000241-13 (Date of registration: 16 January 2012); ClinicalTrials.gov Identifier NCT01643980 (Date of registration: 12 June 2012). |
format | Online Article Text |
id | pubmed-4584019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45840192015-09-28 Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial Cabrera-García, Lourdes Cruz-Melguizo, Sara Ruiz-Antorán, Belén Torres, Ferrán Velasco, Ana Martínez-Payo, Cristina Avendaño-Solá, Cristina Trials Study Protocol BACKGROUND: Premature birth is considered one of the main problems in modern Obstetrics. It causes more than 50 % of neonatal mortality; it is responsible for a large proportion of infant morbidity and incurs very high economic costs. Cervical length, which can be accurately measured by ultrasound, has an inverse relationship with the risk of preterm birth. As a result, having an effective intervention for asymptomatic patients with short cervix could reduce the prematurity. Although recently published data demonstrates the effectiveness of vaginal progesterone and cervical pessary, these treatments have never been compared to one another. METHODS/DESIGN: The PESAPRO study is a noncommercial, multicenter, open-label, randomized clinical trial (RCT) in pregnant women with a short cervix as identified by transvaginal ultrasonography at 19 to 22 weeks of gestation. Patients are randomized (1:1) to either daily vaginal progesterone or cervical pessary until the 37th week of gestation or delivery; whichever comes first. During the trial, women visit every 4 weeks for routine questions and tests. The primary outcome is the proportion of spontaneous preterm deliveries before 34 weeks of gestation. A sample size of 254 pregnant women will be included at 29 participating hospitals in order to demonstrate noninferiority of placing a pessary versus vaginal progesterone. The first patient was randomized in August 2012, and recruitment of study subjects will continue until the end of December 2015. DISCUSSION: This trial assesses the comparative efficacy and safety between two accepted treatments, cervical pessary versus vaginal progesterone, and it will provide evidence in order to establish clinical recommendations. TRIAL REGISTRATION: EU Clinical Trials Register EudraCT2012-000241-13 (Date of registration: 16 January 2012); ClinicalTrials.gov Identifier NCT01643980 (Date of registration: 12 June 2012). BioMed Central 2015-09-25 /pmc/articles/PMC4584019/ /pubmed/26407852 http://dx.doi.org/10.1186/s13063-015-0964-y Text en © Cabrera-García et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Cabrera-García, Lourdes Cruz-Melguizo, Sara Ruiz-Antorán, Belén Torres, Ferrán Velasco, Ana Martínez-Payo, Cristina Avendaño-Solá, Cristina Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial |
title | Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial |
title_full | Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial |
title_fullStr | Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial |
title_full_unstemmed | Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial |
title_short | Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial |
title_sort | evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (pesapro trial): study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584019/ https://www.ncbi.nlm.nih.gov/pubmed/26407852 http://dx.doi.org/10.1186/s13063-015-0964-y |
work_keys_str_mv | AT cabreragarcialourdes evaluationoftwotreatmentstrategiesforthepreventionofpretermbirthinwomenidentifiedasatriskbyultrasoundpesaprotrialstudyprotocolforarandomizedcontrolledtrial AT cruzmelguizosara evaluationoftwotreatmentstrategiesforthepreventionofpretermbirthinwomenidentifiedasatriskbyultrasoundpesaprotrialstudyprotocolforarandomizedcontrolledtrial AT ruizantoranbelen evaluationoftwotreatmentstrategiesforthepreventionofpretermbirthinwomenidentifiedasatriskbyultrasoundpesaprotrialstudyprotocolforarandomizedcontrolledtrial AT torresferran evaluationoftwotreatmentstrategiesforthepreventionofpretermbirthinwomenidentifiedasatriskbyultrasoundpesaprotrialstudyprotocolforarandomizedcontrolledtrial AT velascoana evaluationoftwotreatmentstrategiesforthepreventionofpretermbirthinwomenidentifiedasatriskbyultrasoundpesaprotrialstudyprotocolforarandomizedcontrolledtrial AT martinezpayocristina evaluationoftwotreatmentstrategiesforthepreventionofpretermbirthinwomenidentifiedasatriskbyultrasoundpesaprotrialstudyprotocolforarandomizedcontrolledtrial AT avendanosolacristina evaluationoftwotreatmentstrategiesforthepreventionofpretermbirthinwomenidentifiedasatriskbyultrasoundpesaprotrialstudyprotocolforarandomizedcontrolledtrial AT evaluationoftwotreatmentstrategiesforthepreventionofpretermbirthinwomenidentifiedasatriskbyultrasoundpesaprotrialstudyprotocolforarandomizedcontrolledtrial |